258 related articles for article (PubMed ID: 25312666)
21. Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management.
Chen JY; Mao JH
World J Pediatr; 2015 Feb; 11(1):29-34. PubMed ID: 25557596
[TBL] [Abstract][Full Text] [Related]
22. The relationship between red cell distribution width and the risk of Henoch-Schönlein purpura nephritis.
Zhu X; Zhang M; Lan F; Wei H; He Q; Li S; Qin X
Br J Biomed Sci; 2018 Jan; 75(1):30-35. PubMed ID: 28990845
[TBL] [Abstract][Full Text] [Related]
23. [The I/D polymorphism of the ACE gene in children with Henoch-Schoenlein purpura].
Brodkiewicz A; Ciechanowicz A; Urbańska A; Peregud-Pogorzelski J; Dzieński P; Subicka D; Fydryk J
Pol Merkur Lekarski; 2000 Apr; 8(46):236-8. PubMed ID: 10897627
[TBL] [Abstract][Full Text] [Related]
24. Association study between matrix metalloproteinase-9 gene (MMP9) polymorphisms and the risk of Henoch-Schönlein purpura in children.
Xu ED; Xiao YF; Wang JJ; Dong L
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323137
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Schönlein purpura nephritis: A meta-analysis.
Tan J; Tang Y; Zhong Z; Yan S; Tan L; Tarun P; Qin W
Int Urol Nephrol; 2019 Jun; 51(6):975-985. PubMed ID: 30989564
[TBL] [Abstract][Full Text] [Related]
26. Obesity is associated with Henoch-Schönlein Purpura Nephritis and development of end-stage renal disease in children.
Zheng X; Chen Q; Chen L
Ren Fail; 2019 Nov; 41(1):1016-1020. PubMed ID: 31735105
[No Abstract] [Full Text] [Related]
27. Inducible nitric oxide synthase gene polymorphisms are associated with a risk of nephritis in Henoch-Schönlein purpura children.
Jiang J; Duan W; Shang X; Wang H; Gao Y; Tian P; Zhou Q
Eur J Pediatr; 2017 Aug; 176(8):1035-1045. PubMed ID: 28593405
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients. Italian Group of Renal Immunopathology.
Amoroso A; Danek G; Vatta S; Crovella S; Berrino M; Guarrera S; Fasano ME; Mazzola G; Amore A; Gianoglio B; Peruzzi L; Coppo R
Nephrol Dial Transplant; 1998 Dec; 13(12):3184-8. PubMed ID: 9870486
[TBL] [Abstract][Full Text] [Related]
29. Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Wang J; Ying Q; Zhong S; Chen Y; Di Y; Dai X; Zheng J; Shen M
Pediatr Neonatol; 2018 Jun; 59(3):238-243. PubMed ID: 28919104
[TBL] [Abstract][Full Text] [Related]
30. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schönlein purpura in children.
Zhou TB; Yin SS
Ren Fail; 2013; 35(3):425-9. PubMed ID: 23356642
[TBL] [Abstract][Full Text] [Related]
31. Variations of tongue coating microbiota in children with Henoch-Schönlein purpura nephritis.
Pang S; Zhao S; Bai X; Song N; Wang S; Yu J; Zhang J; Ding X
Microb Pathog; 2021 Nov; 160():105192. PubMed ID: 34534642
[TBL] [Abstract][Full Text] [Related]
32. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura.
Rueda B; Perez-Armengol C; Lopez-Lopez S; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
J Rheumatol; 2006 Jan; 33(1):69-73. PubMed ID: 16395752
[TBL] [Abstract][Full Text] [Related]
33. [Expression and significance of endothelial microparticles in children with Henoch-Schönlein purpura].
Fu SQ; Guo YJ; Song CL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Oct; 20(10):831-834. PubMed ID: 30369358
[TBL] [Abstract][Full Text] [Related]
34. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
35. The genetics of Henoch-Schönlein purpura: a systematic review and meta-analysis.
He X; Yu C; Zhao P; Ding Y; Liang X; Zhao Y; Yue X; Wu Y; Yin W
Rheumatol Int; 2013 Jun; 33(6):1387-95. PubMed ID: 23325094
[TBL] [Abstract][Full Text] [Related]
36. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain.
Martin J; Paco L; Ruiz MP; Lopez-Nevot MA; Garcia-Porrua C; Amoli MM; Calviño MC; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2005 Jun; 32(6):1081-5. PubMed ID: 15940772
[TBL] [Abstract][Full Text] [Related]
37. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
Buscatti IM; Casella BB; Aikawa NE; Watanabe A; Farhat SCL; Campos LMA; Silva CA
Clin Rheumatol; 2018 May; 37(5):1319-1324. PubMed ID: 29330742
[TBL] [Abstract][Full Text] [Related]
38. Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura.
Yilmaz A; Emre S; Agachan B; Bilge I; Yilmaz H; Ergen A; Isbir T; Sirin A
J Nephrol; 2009; 22(6):726-32. PubMed ID: 19967651
[TBL] [Abstract][Full Text] [Related]
39. Association of the paired box 2 gene polymorphism with the susceptibility and pathogenesis of Henoch‑Schönlein purpura in children.
Chen J; Fang X; Dang X; Wu X; Yi Z
Mol Med Rep; 2015 Mar; 11(3):1997-2003. PubMed ID: 25385517
[TBL] [Abstract][Full Text] [Related]
40. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
